Biotech 助力中小型生物制药企业,灵活推进变革性疗法开发 Play ICON innovation 我们的“AI+”:我们的经验、知识和在科技领域的探索 Play ICON Cares 将意图转化为影响 下载2023 ICON ESG完整报告 领先的智慧型CRO Biotech ICON innovation ICON Cares Dismiss Video Modal Dismiss Video Modal Dismiss Video Mod...
In an ICON survey of 149 biotech professionals, 45% of survey respondents identified protocol design as one the most significant challenges faced when transitioning from preclinical to clinical testing. Here, we discuss considerations for several key elements of protocol development in early phase trials...
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation. Cardiac Safety Solutions End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies. ...
ICON has lead the development of 13 vaccines resulting in FDA/EMA approvals, including the world’s first approved vaccine for COVID-19.We work with global biotech, pharma, government and NGOs in the design, execution, and commercialisation of vaccines to prevent infectious diseases. The number...
模板:BiotechIcon 刷新本页 刷新此页面的缓存吗? 确定 刷新页面会清除缓存并强制显示最近的版本。
参数1可取值:s、m、l、xl。默认为s。支持大写。 如{{BiotechIcon|m}} l可用于二级标题,m可用于三级标题,s可用于正文。xl用于需要大图标时。 例如: 二级标题 三级标题 {{BiotechIcon}} {{BiotechIcon|s}} {{BiotechIcon|m}} {{BiotechIcon|l}} {{BiotechIcon|xl}} 参见...
ICON还荣获了“2022年Fierce Life Sciences‘数据分析/商业智慧类别’Fierce Biotech创新奖”,该奖项认可了ICON的创新能力。获得这一奖项的是ICON专有的One Search工具,该工具通过直观、集成的工作流程和人工智能提供多个数据源的访问权限,帮助用户在第一...
Up to 20 % saving on AICON-BIO™ FlaPure Animal Tissue/Cell Total RNA Extraction Kit (Double Column Type) Learn more Up to 10 % saving on Restriction Endonuleases Learn more Up to 10 % saving on GS AntiQ qPCR SYBR Green Master Mix Learn more Featured Products AICON-BIO™ ...
ICON Strategic Solutions teams are embedded in our clients' businesses, working as a dedicated resource within some of the world’s leading Pharmaceutical & Biotech companies. As the largest global provider of Functional Service Provision (FSP) with over 90 partnerships and 13,000+ employees, we...
Chris Smyth, President of ICON Biotech, commented: “Biotech companies’ lean structural models mean they outsource a large proportion of their clinical development and R&D activity. Under financial constraints they often use ad-hoc outsourcing contracts that can be costly and may not offer ...